irinotecan has been researched along with erythrosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Efferth, T; Eichhorn, T; Korn, B; Paulsen, M; Wiench, B | 1 |
| Elshawadfy, R; Namasivayam, V; Silbermann, K; Stefan, SM; Wiese, M | 1 |
| Edaki, K; Liu, W; Mizoi, K; Nakazawa, Y; Ogihara, T; Sunakawa, H; Takahashi, S; Zhang, X | 1 |
3 other study(ies) available for irinotecan and erythrosine
| Article | Year |
|---|---|
Utilizing inherent fluorescence of therapeutics to analyze real-time uptake and multi-parametric effector kinetics.
Topics: Antineoplastic Agents; Biological Transport; Camptothecin; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Fluorescence; Humans; Irinotecan; Kinetics; Mitoxantrone; Reactive Oxygen Species; Single-Cell Analysis | 2012 |
Identification of Thienopyrimidine Scaffold as an Inhibitor of the ABC Transport Protein ABCC1 (MRP1) and Related Transporters Using a Combined Virtual Screening Approach.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Chlorophyll; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluoresceins; Humans; Irinotecan; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pyrimidines; Small Molecule Libraries; Thiophenes | 2019 |
Slug Mediates MRP2 Expression in Non-Small Cell Lung Cancer Cells.
Topics: Biological Transport; Carcinoma, Non-Small-Cell Lung; Fluoresceins; Humans; Irinotecan; Lung Neoplasms; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; RNA, Messenger; Snail Family Transcription Factors | 2022 |